(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 212.49% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Femasys's revenue in 2024 is $1,093,103.On average, 2 Wall Street analysts forecast FEMY's revenue for 2024 to be $83,351,049, with the lowest FEMY revenue forecast at $58,453,982, and the highest FEMY revenue forecast at $108,248,115. On average, 1 Wall Street analysts forecast FEMY's revenue for 2025 to be $361,548,704, with the lowest FEMY revenue forecast at $361,548,704, and the highest FEMY revenue forecast at $361,548,704.
In 2026, FEMY is forecast to generate $740,417,107 in revenue, with the lowest revenue forecast at $740,417,107 and the highest revenue forecast at $740,417,107.